Affinia Therapeutics has received FDA orphan drug designation for AFTX-201, a treatment in development for BAG3-associated DCM.The post Affinia Therapeutics...
bioAffinity Technologies has collaborated with Pictor to develop and commercialise new diagnostic tests for asthma and COPD.The post bioAffinity and...
Pharmaceutical company Ribo have reported initial results from its Phase IIa trial of vortosiran in chronic coronary artery disease patients...
Philips has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its next-generation reusable SpO₂ clip sensor.The...
Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine...
Cellares and Papillon Therapeutics have entered into a partnership to automate the manufacturing of PPL-001, an investigational therapy developed by...
ARUP Laboratories has launched the clinical CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry assay for multiple myeloma.The post ARUP...
Akagera Medicines has reported positive data from the SAD segment of its first-in-human Phase I trial of AKG-100, an investigational...
Halozyme Therapeutics has signed a global partnership and licence agreement with Incyte to assess additional subcutaneous formulations of INCA033989 in...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.